Kremsner P G, Neifer S, Zotter G M, Bienzle U, Rocha R M, Maracic M, Clavijo P, Nussenzweig R S, Cochrane A H
Landesinstitut für Tropenmedizin Berlin, Germany.
Trans R Soc Trop Med Hyg. 1992 Jan-Feb;86(1):23-7. doi: 10.1016/0035-9203(92)90423-a.
A seroepidemiological study of the prevalence of antibodies against the repeating epitopes of circumsporozoite (CS) proteins of human malaria parasites was conducted in 2 different areas in the state of Acre, Brazil in 1987 and 1990. In 1987 antibodies against the CS protein of the VK 247 variant Plasmodium vivax as well as antibodies against the CS proteins of P. falciparum and the classic P. vivax were found at relatively high rates in the 2 areas, but significant microepidemiological differences were observed. In 1990, when large scale migration in Amazonia had ceased and control measures were applied in the study areas, the malaria endemicity decreased, as determined by the declining prevalence of anti-sporozoite antibodies against all Plasmodium species, and the small number of individuals with positive blood smears. Antibodies against sporozoites of the variant P. vivax did not cross-react with the CS proteins of the classic P. vivax, nor with antibodies against sporozoites of P. falciparum and P. malariae. Sera containing antibodies against the CS protein of P. malariae were found at a very low frequency, and only in 1987. The anti-CS protein antibody response to all Plasmodium species was age-related.
1987年和1990年,在巴西阿克里州的两个不同地区开展了一项血清流行病学研究,以调查针对人类疟原虫环子孢子(CS)蛋白重复表位的抗体流行情况。1987年,在这两个地区发现,针对间日疟原虫VK 247变异体CS蛋白的抗体以及针对恶性疟原虫和经典间日疟原虫CS蛋白的抗体发生率相对较高,但观察到显著的微观流行病学差异。1990年,当亚马逊地区的大规模移民停止且研究地区实施了控制措施后,疟疾病地方性流行程度下降,这是通过针对所有疟原虫物种的抗子孢子抗体流行率下降以及血涂片阳性个体数量减少来确定的。针对间日疟原虫变异体子孢子的抗体与经典间日疟原虫的CS蛋白不发生交叉反应,也不与针对恶性疟原虫和三日疟原虫子孢子的抗体发生交叉反应。仅在1987年发现含有针对三日疟原虫CS蛋白抗体的血清,且频率极低。针对所有疟原虫物种的抗CS蛋白抗体反应与年龄相关。